ANNOVIS BIO

$13.82 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About ANNOVIS BIO

Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsylvania.

Stock Analysis

last close $13.04
1-mo return -35.9%
3-mo return -55.6%
avg daily vol. 104.61T
52-week high 132
52-week low 9.71
market cap. $106M
forward pe -
annual div. -
roe -36.9%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 18.5%
baraka

Subscribe now for daily local and international financial news

Subscribe